Tirzepatide, novel agent for treating type 2 diabetes has different efficacy in Asians and non-Asians: Study
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok